Glass Health Secures $5M for AI-Powered Clinical Decision Support Platform
Glass Health aspires to empower clinicians with transformative AI tools to address the ongoing crisis of clinician burnout and to significantly enhance patient outcomes on a global scale.
Company Name: Glass Health
Location: San Francisco, CA
Nature of Business: AI-powered clinical decision support platform provider.
Funding: $5M in funding.
Lead Investor: Initialized Capital Participants: Tom Lee (founder of One Medical, Epocrates, and Galileo Health), Connor Landgraf (founder and CEO of Eko Health), and Heather Hasson & Trina Spear (co-founders of FIGS), among others.
Participating Investors: Breyer Capital, and Y Combinator
Purpose of Funding:
- Expand its operations.
- Intensify development efforts.
Background: Headed by Dereck Paul, MD, Glass Health aspires to empower clinicians with transformative AI tools to address the ongoing crisis of clinician burnout and to significantly enhance patient outcomes on a global scale. The firm's platform harnesses the potential of large language models, aiding in differential diagnosis and the crafting of clinical plans.
With a vision to forge significant partnerships, Glass Health aims to collaborate with a diverse range of entities including hospitals, health systems, and medical training programs.
